Oren Gershtein

JVP Media Labs (JVP Media Labs) is a venture capital subsidiary of Jerusalem Venture Partners founded in 2003 by Erel N. Margalit. The firm is headquartered in Jerusalem, Israel.

OMS Displays Ltd. develops backlight units for liquid crystal displays TVs. The company develops optical magnifying sheets providing solutions for manufacturing magnifying panels for the display industry. The company was founded by Yosi Shani in 2005 and is headquartered in Jerusalem, Israel.

Secure Islands Technologies Ltd. develops and markets information protection and control solutions. Its services include securere islands IQprotector training, quick start program, on-site consulting and implementation, microsoft RMS consulting, planning and implementation. The company was founded by Aki Eldar and Yuval Eldar in 2006 and is headquartered in Beit-Dagan, Israel.

OptiCul Diagnostics Ltd. designs, patents and markets medical diagnosis devices. The firm's devices measure the response of various samples, such as bodily fluids and secretions, and analyze them to detect the presence of different bacteria. The company was founded by Moshe Ben-David, Shimon Eckhouse, Israel Gannot and Gallya Gannot in January 2008 and is headquartered in Jerusalem, Israel.

EVE Medical Systems Ltd. developed system for diagnosis and treatment of severe premenstrual syndrome in women. Its products included diagnostics of sensitivity to female reproductive hormones, which predominated in the severe cases of different hormone-related conditions, such as premenstrual syndrome unexplained recurrent abortions and personalized treatment solutions. The company was founded by Igor Derzy and Alek M. Itsekson on May 18, 2008 and was headquartered in Jerusalem, Israel.

Bio-MarCare Technologies Ltd. develops diagnostic kits based on novel biomarkers for early cancer identification, monitoring and assistance. Its product mCRC-Strat is a personalized medicine assay predicting responsiveness to anti EGFR therapy and Colon-MarCarePlex is a molecular assay (qRT-PCR) comprising a panel of RNA markers that can detect the advanced adenoma polyps as well as early stage colorectal cancer. The company was founded by Beatrice Uziely and Rachel Bar-Shavit in 2002 and is headquartered in Jerusalem, Israel.

Promyco Diagnostics has recognized the unmet need for sensitive and accurate serological diagnostic kits for the detection of genital mycoplasma infections. Promyco Diagnostics' research laboratories are located at Soroka University Medical Center, Beer Sheba, Israel. The development of its novel commercial kit is based on the extensive knowledge and expertise accumulated at the NationalCenter for Mycoplasma Laboratory, in the same institution, which specializes and centralizes the clinical testing of mycoplasma infections from samples throughout Israel. This Center was founded and lead for over 20 years by Promyco Diagnostics' scientific leader, Professor Shulamith Horowitz. Promyco Diagnostics' novel serological kit is already in use at this laboratory; many hundreds of samples have proved the concept behind its technology, which will be shortly translated into a simple and accurate commercial kit. The company was founded by Mor Research Applications, the technology transfer company of Israel's biggest Health Care Services, Kupat Holim Clalit, and Van Leer Ventures, one of the leading early stage investment centers.

Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel.